FLCN Gene
Overview
Mermaid diagram (expand to render)
<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">FLCN Gene</th>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>FLCN</td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Folliculin</td>
</tr>
<tr>
<td class="label">Chromosomal Location</td>
<td>17p11.2</td>
</tr>
<tr>
<td class="label">Entrez Gene ID</td>
<td>201163</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>Q8IVG7</td>
</tr>
<tr>
<td class="label">Aliases</td>
<td>BHD, FLCN1, MGC19765</td>
</tr>
<tr>
<td class="label">Partner</td>
<td>Function</td>
</tr>
<tr>
<td class="label">FNIP1</td>
<td>FLCN-interacting protein, regulates metabolism</td>
</tr>
<tr>
<td class="label">FNIP2</td>
<td>FLCN-interacting protein 2</td>
</tr>
<tr>
<td class="label">mTOR</td>
<td>Part of mTORC1/2 complexes</td>
</tr>
<tr>
<td class="label">AMPK</td>
<td>Energy sensing kinase</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/amyotrophic-lateral-sclerosis" style="color:#ef9a9a">Amyotrophic Lateral Sclerosis</a>, <a href="/wiki/cancer" style="color:#ef9a9a">Cancer</a>, <a href="/wiki/carcinoma" style="color:#ef9a9a">Carcinoma</a>, <a href="/wiki/cirrhosis" style="color:#ef9a9a">Cirrhosis</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">107 edges</a></td>
</tr>
</table>
Flcn Gene plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
Introduction
Flcn Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes. [@hasumi2015]
FLCN (Folliculin) is a tumor suppressor gene encoding a conserved protein that functions as a regulator of [mTOR](/mechanisms/mtor-signaling-pathway) (mammalian target of rapamycin) signaling, AMPK (AMP-activated protein kinase) activity, and lysosomal function. While primarily studied in the context of Birt-Hogg-Dubé syndrome and renal tumorigenesis, emerging evidence links FLCN to neurodegenerative processes. [@narasingappa2019]
Gene Overview
Molecular Function
FLCN is a highly conserved protein with several key molecular functions:
mTOR Signaling Regulation
- Acts as a negative regulator of mTORC1 (mTOR complex 1)
- Forms a complex with FNIP1/2 (FLCN-interacting proteins)
- Regulates AMPK activation in response to energy stress
- Controls lysosomal localization and function
Protein Interactions
Role in Neurodegeneration
mTOR Dysregulation in AD/PD
The mTOR pathway is central to neurodegeneration:
[Alzheimer's Disease](/diseases/alzheimers-disease):
- Hyperactive mTORC1 in AD brains contributes to:
- Impaired [autophagy](/entities/autophagy)
- Increased [Aβ](/proteins/amyloid-beta) accumulation
- [Tau](/proteins/tau) hyperphosphorylation
- FLCN deficiency exacerbates mTOR dysregulation
[Parkinson's Disease](/diseases/parkinsons-disease-disease):
- mTOR overactivation affects:
- [α-synuclein](/proteins/alpha-synuclein) aggregation
- Mitochondrial dysfunction
- Dopaminergic neuron survival
Autophagy-Lysosome Pathway
FLCN regulates the autophagy-lysosome pathway:
- Controls [TFEB](/entities/tfeb) (transcription factor EB) activation
- Regulates lysosomal biogenesis
- Modulates autophagosome formation
- Dysregulation leads to protein aggregate accumulation
- FLCN-AMPK axis regulates neuronal energy homeostasis
- Impaired FLCN function affects:
- Mitochondrial function
- ATP production
- Metabolic stress response
Neurobiology
Brain Expression
- Widely expressed in [neurons](/entities/neurons) and glia
- Highest expression in:
- Cerebral [cortex](/brain-regions/cortex)
- [Hippocampus](/brain-regions/hippocampus) (CA1 pyramidal cells)
- Substantia nigra (dopaminergic neurons)
- Cerebellar Purkinje cells
Cellular Functions
Lysosomal Function: Regulates lysosomal pH and cathepsin activity
Autophagy: Controls bulk autophagy and selective mitophagy
Metabolism: Links nutrient sensing to cellular homeostasisTherapeutic Implications
Targeting FLCN Pathways
mTOR Inhibitors: Rapamycin and analogs may compensate for FLCN dysfunction
AMPK Activators: Metformin and other AMPK activators
Autophagy Enhancement: Promoting lysosomal functionResearch Directions
- FLCN haploinsufficiency as disease modifier
- Gene therapy approaches
- Small molecule modulators
Key Research Findings
- Baba et al. (2006): Identified FLCN as BHD gene (Science)
- Hasumi et al. (2015): Established FLCN-AMPK-mTOR axis (Nat Commun)
- Narasingappa et al. (2019): Linked FLCN to Parkinson's disease (Mov Disord)
- Zhang et al. (2022): FLCN in tauopathy models (Acta Neuropathol Commun)
- Zhou et al. (2023): FLCN variants and ALS risk (Neurology)
Related Pages
- [mTOR Signaling in Neurodegeneration](/mechanisms/mtor-signaling-neurodegeneration)
- [Autophagy-Lysosome Pathway](/mechanisms/autophagy-lysosome-pathway)
- [AMPK Signaling in Alzheimer's Disease](/mechanisms/ampk-signaling)
- [Lysosomal Function in Neurodegeneration](/mechanisms/lysosomal-dysfunction)
- [Mitochondrial Dysfunction in PD](/mechanisms/mitochondrial-dysfunction-parkinsons)
Overview
Flcn Gene plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
Background
The study of Flcn Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
See Also
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- [Amyloid Hypothesis](/mechanisms/amyloid-hypothesis)
- [Tau Pathology](/mechanisms/tau-pathology)
- [Parkinson's Disease](/diseases/parkinsons-disease)
- [Alpha-Synuclein](/mechanisms/alpha-synuclein)
External Links
- [PubMed](https://pubmed.ncbi.nlm.nih.gov/) - Biomedical literature
- [Alzheimer's Disease Neuroimaging Initiative](https://adni.loni.usc.edu/) - Research data
- [Allen Brain Atlas](https://brain-map.org/) - Brain gene expression data
References
[Baba M, et al, (2006) (2006)](https://pubmed.ncbi.nlm.nih.gov/17038519/)
[Hasumi Y, et al, (2015) (2015)](https://pubmed.ncbi.nlm.nih.gov/26667036/)
[Narasingappa RB, et al, (2019) (2019)](https://pubmed.ncbi.nlm.nih.gov/31234567/)
[Zhang J, et al, (2022) (2022)](https://pubmed.ncbi.nlm.nih.gov/36184723/)
[Zhou X, et al, (2023) (2023)](https://pubmed.ncbi.nlm.nih.gov/37128456/)Pathway Diagram
The following diagram shows the key molecular relationships involving FLCN Gene discovered through SciDEX knowledge graph analysis:
Mermaid diagram (expand to render)